Cohort profile: The Tromsø Study

The Tromso Study was initiated in 1974 in an attempt to help combat the high mortality of cardiovascular diseases in Norway, that was particularly pronounced among middle-aged men. In the mid-1970s, Norwegian men had a 20% risk of dying of myocardial infarction (MI) before the age of 75 years. The situation in Northern Norway was even worse. The primary aim of the Tromso Study was to determine causes of the high cardiovascular mortality, and also to develop ways of preventing heart attacks and strokes. This was reflected through the first name of the study: The Tromso Heart Study. However, during the 37 years since the first examination of the Tromso Study took place, increasing emphasis has been put on other chronic diseases and conditions, in particular atrial fibrillation, venous thromboembolism, diabetes mellitus, osteoporosis and fractures. It has been a deliberate policy to invite a wide range of faculty research groups to join in with subprojects in the surveys, and there are currently some 100 different ongoing research projects based on the data from the consecutive six surveys. The study was initially funded by the University of Tromso, and has been so for the entire period since 1974, but there have also been substantial contributions, directly and indirectly from, for example, the National Screening Services, the Research Council of Norway, Northern Norway Regional Health Authority, Norwegian Council on Cardiovascular Diseases and Norwegian Foundation for Health and Rehabilitation. Teams of investigators approach public research programmes for funding of the different examinations conducted. Tromso is the largest city in Northern Norway. It is situated 400 km north of the Arctic Circle, and has approximately 67 000 inhabitants. The physical living conditions are dominated by dramatic changes in the light with 2 months of midnight sun and 2 months of the polar night. However, due to the Gulf Stream, the climate is relatively mild, the latitude (698N) taken into account.

[1]  Camilla,et al.  A sequence variant in ZFHX 3 on 16 q 22 associates with atrial fibrillation and ischemic stroke , 2009 .

[2]  C. Gieger,et al.  A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke , 2009, Nature Genetics.

[3]  O. Joakimsen,et al.  Echolucent Plaques Are Associated With High Risk of Ischemic Cerebrovascular Events in Carotid Stenosis: The Tromsø Study , 2001, Circulation.

[4]  D. Thelle,et al.  THE TROMSØHEART-STUDY HIGH-DENSITY LIPOPROTEIN AND CORONARY HEART-DISEASE: A PROSPECTIVE CASE-CONTROL STUDY , 1977, The Lancet.

[5]  K. Bønaa,et al.  Prevalence of and risk factors for abdominal aortic aneurysms in a population-based study : The Tromsø Study. , 2001, American journal of epidemiology.

[6]  Erik Buskens,et al.  Prevalence of Asymptomatic Carotid Artery Stenosis in the General Population: An Individual Participant Data Meta-Analysis , 2010, Stroke.

[7]  Bjørn Møller,et al.  Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. , 2009, European journal of cancer.

[8]  H Tunstall-Pedoe,et al.  The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases , 2007, European Journal of Epidemiology.

[9]  S. Knutsen,et al.  The Tromsø Survey: the Family Intervention study--the effect of intervention on some coronary risk factors and dietary habits, a 6-year follow-up. , 1991, Preventive medicine.

[10]  G. Moneta,et al.  Major Lipids, Apolipoproteins, and Risk of Vascular Disease , 2010 .

[11]  D. Thelle,et al.  The Tromsø Heart Study: Serum apolipoprotein Al concentration in relation to future coronary heart disease , 1978, European journal of clinical investigation.

[12]  J. Danesh,et al.  Major lipids, apolipoproteins, and risk of vascular disease. , 2009, JAMA.

[13]  O. Joakimsen,et al.  Carotid Atherosclerosis Is a Stronger Predictor of Myocardial Infarction in Women Than in Men: A 6-Year Follow-Up Study of 6226 Persons: The Tromsø Study , 2007, Stroke.

[14]  B. Jacobsen,et al.  The Tromsø Heart Study: Responders and Non-responders to a Health Questionnaire, Do They Differ? , 1988, Scandinavian journal of social medicine.

[15]  O H Førde,et al.  The Tromsø Study. Distribution and population determinants of gamma-glutamyltransferase. , 1990, American journal of epidemiology.

[16]  I. Njølstad,et al.  Increase in weight in all birth cohorts in a general population: The Tromsø Study, 1974-1994. , 2001, Archives of internal medicine.

[17]  K. Bønaa,et al.  Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension. A population-based intervention trial from the Tromsø study. , 1990, The New England journal of medicine.

[18]  Ivar Heuch,et al.  Association of albuminuria and cancer incidence. , 2008, Journal of the American Society of Nephrology : JASN.

[19]  B. Eriksen,et al.  The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. , 2006, Kidney international.

[20]  Anders Engeland,et al.  COHORT PROFILE Cohort Profile: Cohort of Norway (CONOR) , 2007 .

[21]  Ivar Heuch,et al.  The combined effect of albuminuria and inflammation on all‐cause and cardiovascular mortality in nondiabetic persons , 2008, Journal of internal medicine.

[22]  B. Jacobsen,et al.  Risk factors for coronary heart disease and level of education. The Tromsø Heart Study. , 1988, American journal of epidemiology.

[23]  D. Thelle,et al.  The Tromsøo heart study. Methods and main results of the cross-sectional study. , 2009, Acta medica Scandinavica.

[24]  K. Bønaa,et al.  Coffee and cholesterol: is it all in the brewing? The Tromsø Study. , 1988, BMJ.

[25]  Vinjar Fønnebø,et al.  The Tromsø Study , 1995, Scandinavian journal of social medicine.

[26]  K. Bønaa,et al.  Serum total homocysteine and coronary heart disease. , 1995, International journal of epidemiology.

[27]  S. Isomura,et al.  CONTACT INFECTION FROM LIVE VARICELLA VACCINE RECIPIENTS , 1976, The Lancet.

[28]  J. Gran,et al.  Prevalence of ankylosing spondylitis in males and females in a young middle-aged population of Tromsø, northern Norway. , 1985, Annals of the rheumatic diseases.

[29]  S. Knutsen,et al.  The Tromsø Heart Study , 1989, Scandinavian journal of social medicine.

[30]  E. Mathiesen,et al.  Weight loss and mortality: a gender-specific analysis of the Tromsø study. , 2009, Gender medicine.

[31]  E. Arnesen,et al.  The Tromsø heart study. Does coffee raise serum cholesterol? , 1983, The New England journal of medicine.